Clinical Trial Results:
A multicenter, randomized, open-label, blinded endpoint evaluation, active-controlled Phase 2 study to compare the efficacy and safety of s.c. MAA868 versus s.c. enoxaparin in adult patients undergoing unilateral total knee arthroplasty
Summary
|
|
EudraCT number |
2017-002925-39 |
Trial protocol |
ES AT CZ IT |
Global completion date |
01 Jul 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
17 Oct 2019
|
First version publication date |
17 Oct 2019
|
Other versions |
|
Summary report(s) |
Terminatio Letter for CMAA868A2201 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.